A Mechanism for Cancer-Associated Membranous Nephropathy.
Hoxha E, Wiech T, Stahl PR, Zahner G, Tomas NM, Meyer-Schwesinger C, Wenzel U, Janneck M, Steinmetz OM, Panzer U, Harendza S, Stahl RA
N Engl J Med. 2016 May
A pathogenic role of complement in arterial hypertension and hypertensive end organ damage.
Wenzel UO, Bode M, Köhl J, Ehmke H
Am J Physiol Heart Circ Physiol. 2017 Mar
B6.Rag1 Knockout Mice Generated at the Jackson Laboratory in 2009 Show a Robust Wild-Type Hypertensive Phenotype in Response to Ang II (Angiotensin II).
Seniuk A, Thiele JL, Stubbe A, Oser P, Rosendahl A, Bode M, Meyer-Schwesinger C, Wenzel UO, Ehmke H.
Hypertension. 2020 Apr
Immune Mechanisms in Arterial Hypertension
Wenzel U, Turner J, Krebs C, Kurts C, Harrison D, Ehmke H
J Am Soc Nephrol. 2016 Mar
Salt, inflammation, IL-17 and hypertension.
Wenzel UO, Bode M, Kurts C, Ehmke H.
Br J Pharmacol. 2018 May
The chemokine receptor CX3CR1 reduces renal injury in mice with angiotensin II induced hypertension
Ahadzadeh E, Rosendahl A, Czesla D, Steffens P, Prüßner L, Meyer-Schwesinger C, Wanner N, Paust H, Huber T, Stahl R, Wiech T, Kurts C, Seniuk A, Ehmke H, Wenzel U
Am J Physiol Renal Physiol. 2018 Sep
The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension.
Weiss S, Rosendahl A, Czesla D, Meyer-Schwesinger C, Stahl RA, Ehmke H, Kurts C, Zipfel PF, Köhl J, Wenzel UO
Am J Physiol Renal Physiol. 2016 Jun